Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 44 out of 100. Down syndrome and Alzheimer's

Topic: Amyloid, tau and blood-test diagnosis

Results Of 93 participants, mean (SD) age was 39.6 (8.6) years and 41.9% were female. After adjustment, higher IV (indicating fragmentation of RAR in a 24-hour period) was associated with increased levels of pTau181 (standardized beta [β]: 0.21, p = 0.03). Higher RA (indicating robust RAR) and higher SRI (indicating consistent and regular sleep patterns) were associated with lower pTau181 (β: -0.21, p = 0.02 and β: -0.20, p = 0.03, respectively). In the subsample of participants who had amyloid PET data available at the time of analysis (n = 29), higher IV was associated with increased centiloids (β = 0.30, p = 0.04). In the exploratory analysis, higher pTau181 was associated with increased odds-ratio for MCI and AD (OR: 1.021, 95% CI: 1.004 to 1.038; p = 0.02). Conclusion These findings suggest that circadian rhythm disruption as measured via 24-hour RAR is associated with plasma and imaging biomarkers of AD in DS.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Chung, P. A., Fleming, V., Reid, K., Plante, D., Hom, C. L., Ances, B. M., et al. (2026). B31-13 Circadian Rest-Activity Rhythm and Alzheimer’s Disease Biomarkers in Adults With Down Syndrome. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1093/ajrccm/aamag162.6475

Vancouver

Chung PA, Fleming V, Reid K, Plante D, Hom CL, Ances BM, et al. B31-13 Circadian Rest-Activity Rhythm and Alzheimer’s Disease Biomarkers in Adults With Down Syndrome. American Journal of Respiratory and Critical Care Medicine. 2026. doi:10.1093/ajrccm/aamag162.6475.

BibTeX

@article{chung2026-02ad0ff8,
  author  = {Chung, Paul A. and Fleming, Victoria and Reid, K and Plante, D and Hom, Christy L. and Ances, Beau M. and Handen, B and Christian, Bradley T. and others},
  title   = {{B31-13 Circadian Rest-Activity Rhythm and Alzheimer’s Disease Biomarkers in Adults With Down Syndrome}},
  journal = {American Journal of Respiratory and Critical Care Medicine},
  year    = {2026},
  doi     = {10.1093/ajrccm/aamag162.6475},
  url     = {https://doi.org/10.1093/ajrccm/aamag162.6475}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

In adults with Down syndrome, more fragmented rest-activity rhythms were associated with higher pTau181 and, in a small subsample, with more amyloid on PET. This is a cross-sectional association and does not show that changing sleep or circadian rhythms would treat, cure or prevent Alzheimer's disease.

Study details

How this study scored 44/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 4 of 4; Study design 4 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 1 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 1 of 4; Institution's track record 2 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 1 of 2; Free to read 0 of 2. Total 44 of 100.44 of 100 points earned56 not earned

Published in a peer-reviewed journal, and it is a snapshot of people at one point in time. Scored zero for randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (American Journal of Respiratory and Critical Care Medicine)
Journal's citation record 4 / 4 American Journal of Respiratory and Critical Care Medicine: journal h-index 507 (OpenAlex, 2026-10-29)
Study design 4 / 12 A snapshot of people at one point in time
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 1 / 4 29 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Phyllis C. Zee: h-index 6 (OpenAlex, whole career)
Institution's track record 2 / 3 Washington University in St. Louis: institution h-index 1,962 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 6 institution(s) in 1 country
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Total 44 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.

Studies in the library that share something with this one. The line above each title says what.

Related studies in Down syndrome and Alzheimer's

Also tagged “down”

527 studies in the library carry the topic tag “down”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 527 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Down syndrome and Alzheimer's

See all studies in Down syndrome and Alzheimer's →